经临床评估用于治疗慢性炎症性疾病的选择性p38α抑制剂。 - Suppr

Selective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disorders.

作者信息

Goldstein David M, Kuglstatter Andreas, Lou Yan, Soth Michael J

机构信息

Roche Palo Alto, 3431 Hillview Avenue, Palo Alto, California 94304, USA.

出版信息

J Med Chem. 2010 Mar 25;53(6):2345-53. doi: 10.1021/jm9012906.

DOI:10.1021/jm9012906

PMID:19950901

Abstract

摘要

相似文献

Selective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disorders.

J Med Chem. 2010 Mar 25;53(6):2345-53. doi: 10.1021/jm9012906.

SCIO-469 Scios Inc.

Curr Opin Investig Drugs. 2004 Nov;5(11):1205-12.

Drug evaluation: VX-702, a MAP kinase inhibitor for rheumatoid arthritis and acute coronary syndrome.

Curr Opin Investig Drugs. 2006 Nov;7(11):1020-5.

Inhibition of p38: has the fat lady sung?

Arthritis Rheum. 2009 Feb;60(2):317-20. doi: 10.1002/art.24264.

Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis.

Curr Opin Investig Drugs. 2003 May;4(5):566-71.

Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity.

J Pharmacol Exp Ther. 2008 Dec;327(3):610-9. doi: 10.1124/jpet.108.139006. Epub 2008 Sep 5.

Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase.

Bioorg Med Chem Lett. 2009 Oct 15;19(20):5851-6. doi: 10.1016/j.bmcl.2009.08.082. Epub 2009 Aug 27.

Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation.

J Med Chem. 2005 Jan 27;48(2):414-26. doi: 10.1021/jm049575n.

p38 MAP kinase inhibitors: many are made, but few are chosen.

Curr Opin Drug Discov Devel. 2005 Jul;8(4):421-30.

Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitors.

Bioorg Med Chem Lett. 2008 Apr 15;18(8):2652-7. doi: 10.1016/j.bmcl.2008.03.019. Epub 2008 Mar 10.

引用本文的文献

Development of Potent Type V MAPK Inhibitors: Design, Synthesis, and Biological Evaluation of Benzothiazole Derivatives Targeting p38α MAPK in Breast Cancer Cells.

Arch Pharm (Weinheim). 2025 Apr;358(4):e2500011. doi: 10.1002/ardp.202500011.

First-in-class ultralong-target-residence-time p38α inhibitors as a mitosis-targeted therapy for colorectal cancer.

Nat Cancer. 2025 Feb;6(2):259-277. doi: 10.1038/s43018-024-00899-7. Epub 2025 Jan 16.

Revisiting p38 Mitogen-Activated Protein Kinases (MAPK) in Inflammatory Arthritis: A Narrative of the Emergence of MAPK-Activated Protein Kinase Inhibitors (MK2i).

Pharmaceuticals (Basel). 2023 Sep 12;16(9):1286. doi: 10.3390/ph16091286.

Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry.

Pharmaceuticals (Basel). 2023 Jul 12;16(7):997. doi: 10.3390/ph16070997.

CC-99677, a novel, oral, selective covalent MK2 inhibitor, sustainably reduces pro-inflammatory cytokine production.

Arthritis Res Ther. 2022 Aug 18;24(1):199. doi: 10.1186/s13075-022-02850-6.

Recent clinical findings on the role of kinase inhibitors in COVID-19 management.

Life Sci. 2022 Oct 1;306:120809. doi: 10.1016/j.lfs.2022.120809. Epub 2022 Jul 13.

Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy.

Eur Heart J. 2022 Sep 21;43(36):3477-3489. doi: 10.1093/eurheartj/ehac305.

Strategies for Improving Photodynamic Therapy Through Pharmacological Modulation of the Immediate Early Stress Response.

Methods Mol Biol. 2022;2451:405-480. doi: 10.1007/978-1-0716-2099-1_20.

A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease.

Alzheimers Res Ther. 2021 May 27;13(1):106. doi: 10.1186/s13195-021-00843-2.

P38 mitogen activated protein kinase inhibitor improves platelet in vitro parameters and in vivo survival in a SCID mouse model of transfusion for platelets stored at cold or temperature cycled conditions for 14 days.

PLoS One. 2021 May 11;16(5):e0250120. doi: 10.1371/journal.pone.0250120. eCollection 2021.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Selective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disorders.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献